A logo

Agilent Technologies, Inc. (A) EBITDA

Annual EBITDA:

$1.77B-$83.00M(-4.49%)
October 31, 2025

Summary

  • As of today, A annual EBITDA is $1.77 billion, with the most recent change of -$83.00 million (-4.49%) on October 31, 2025.
  • During the last 3 years, A annual EBITDA has fallen by -$132.00 million (-6.95%).
  • A annual EBITDA is now -6.95% below its all-time high of $1.90 billion, reached on October 31, 2022.

Performance

1-Year Change

-4.49%

3-Year Change

-6.95%

5-Year Change

+39.9%

15-Year Change

+58.19%

A EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

95.77%
A annual EBITDA is higher than 95.77% of companies in Healthcare sector

Range

All-Time High

$1.90B
A annual EBITDA is currently -6.95% below its historical high of $1.90 billion

3-Year Low

$1.77B
A annual EBITDA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Oct 31, 2025
A previous annual earnings announcement was published on Oct 31, 2025

Next Annual Earnings Report Date

N/A
A next annual earnings announcement has not yet been scheduled

OtherAincome statement metrics

Annual Revenue

$6.95B
A annual revenue is $6.95 billion

Annual Net Income

$1.30B
A annual net profit is $1.30 billion

Annual EBIT

$1.48B
A annual earnings before interest & taxes is $1.48 billion

Annual EPS

$4.57
A annual earnings per share is $4.57

Quarterly EBITDA:

$514.00M+$57.00M(+12.47%)
October 31, 2025

Summary

  • As of today, A quarterly EBITDA is $514.00 million, with the most recent change of +$57.00 million (+12.47%) on October 31, 2025.
  • Over the past year, A quarterly EBITDA has increased by +$17.00 million (+3.42%).
  • A quarterly EBITDA is now -75.37% below its all-time high of $2.09 billion, reached on July 31, 1999.

Performance

3-Month Change

+12.47%

1-Year Change

+3.42%

3-Year Change

+4.05%

5-Year Change

+34.2%

A Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

95.38%
A quarterly EBITDA is higher than 95.38% of companies in Healthcare sector

Range

All-Time High

$2.09B
A quarterly EBITDA is currently -75.37% below its historical high of $2.09 billion

3-Year Low

$426.00M
A quarterly EBITDA is currently +20.66% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Oct 31, 2025
A previous earnings announcement was published on Oct 31, 2025

Next Quarterly Earnings Report Date

Feb 25, 2026
A next earnings announcement is scheduled for Feb 25, 2026

OtherAincome statement metrics

Quarterly Revenue

$1.86B
A quarterly revenue is $1.86 billion

Quarterly Net Income

$434.00M
A quarterly net profit is $434.00 million

Quarterly EBIT

$443.00M
A quarterly earnings before interest & taxes is $443.00 million

Quarterly EPS

$1.53
A quarterly earnings per share is $1.53

TTM EBITDA:

$1.86B+$17.00M(+0.92%)
October 31, 2025

Summary

  • As of today, A TTM EBITDA is $1.86 billion, with the most recent change of +$17.00 million (+0.92%) on October 31, 2025.
  • Over the past year, A TTM EBITDA has increased by +$11.00 million (+0.59%).
  • A TTM EBITDA is now -70.17% below its all-time high of $6.25 billion, reached on October 31, 1999.

Performance

3-Month Change

+0.92%

1-Year Change

+0.59%

3-Year Change

-1.84%

5-Year Change

+47.59%

A TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

95.47%
A TTM EBITDA is higher than 95.47% of companies in Healthcare sector

Range

All-Time High

$6.25B
A TTM EBITDA is currently -70.17% below its historical high of $6.25 billion

3-Year Low

$1.84B
A TTM EBITDA is currently +1.30% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Oct 31, 2025
A previous earnings announcement was published on Oct 31, 2025

Next Quarterly Earnings Report Date

Feb 25, 2026
A next earnings announcement is scheduled for Feb 25, 2026

OtherAincome statement metrics

TTM Revenue

$6.95B
A TTM revenue is $6.95 billion

TTM Net Income

$1.30B
A TTM net profit is $1.30 billion

TTM EBIT

$1.58B
A TTM earnings before interest & taxes is $1.58 billion

TTM EPS

$4.57
A TTM earnings per share is $4.57

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

$1.77B
A annual EBITDA is $1.77 billion

Annual Net Income

$1.30B
A annual net profit is $1.30 billion

Annual Interest Expense

$0.00
A annual interest expense is $0.00

Annual Income Tax

$132.00M
A annual income tax is $132.00 million

Annual D&A

$288.00M
A annual D&A is $288.00 million

A EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-4.5%+3.4%+0.6%
3Y3 Years-7.0%+4.0%-1.8%
5Y5 Years+39.9%+34.2%+47.6%

A EBITDA Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-7.0%at lowat high+20.7%-5.1%+1.3%
5Y5-Year-7.0%+39.9%at high+38.5%-5.1%+47.6%
All-TimeAll-Time-7.0%+302.6%-75.4%+212.0%-70.2%+264.8%

A EBITDA History

DateAnnualQuarterlyTTM
Oct 2025
$1.77B(-4.5%)
$514.00M(+12.5%)
$1.86B(+0.9%)
Jul 2025
-
$457.00M(+5.5%)
$1.85B(-0.6%)
Apr 2025
-
$433.00M(-5.9%)
$1.86B(+0.4%)
Jan 2025
-
$460.00M(-7.4%)
$1.85B(-0.1%)
Oct 2024
$1.85B(-2.6%)
$497.00M(+6.2%)
$1.85B(+0.7%)
Jul 2024
-
$468.00M(+9.9%)
$1.84B(+0.1%)
Apr 2024
-
$426.00M(-7.8%)
$1.84B(-1.9%)
Jan 2024
-
$462.00M(-4.7%)
$1.88B(-2.1%)
Oct 2023
$1.90B(0.0%)
$485.00M(+3.9%)
$1.92B(-0.5%)
Jul 2023
-
$467.00M(+1.1%)
$1.93B(-2.0%)
Apr 2023
-
$462.00M(-8.0%)
$1.97B(+1.8%)
Jan 2023
-
$502.00M(+1.6%)
$1.93B(+1.6%)
Oct 2022
$1.90B(+12.5%)
$494.00M(-2.6%)
$1.90B(+2.1%)
Jul 2022
-
$507.00M(+18.7%)
$1.86B(+4.6%)
Apr 2022
-
$427.00M(-9.3%)
$1.78B(+3.3%)
Jan 2022
-
$471.00M(+3.5%)
$1.72B(+3.5%)
Oct 2021
$1.69B(+33.7%)
$455.00M(+7.1%)
$1.66B(+4.5%)
Jul 2021
-
$425.00M(+14.6%)
$1.59B(+7.9%)
Apr 2021
-
$371.00M(-10.0%)
$1.48B(+7.1%)
Jan 2021
-
$412.00M(+7.6%)
$1.38B(+9.0%)
Oct 2020
$1.26B(+7.8%)
$383.00M(+23.9%)
$1.26B(+5.1%)
Jul 2020
-
$309.00M(+13.2%)
$1.20B(+2.5%)
Apr 2020
-
$273.00M(-8.4%)
$1.17B(+0.4%)
Jan 2020
-
$298.00M(-7.5%)
$1.17B(0.0%)
Oct 2019
$1.17B(+4.9%)
$322.00M(+15.0%)
$1.17B(+2.2%)
Jul 2019
-
$280.00M(+4.5%)
$1.14B(+0.4%)
Apr 2019
-
$268.00M(-10.1%)
$1.14B(+0.3%)
Jan 2019
-
$298.00M(+0.3%)
$1.14B(+0.7%)
Oct 2018
$1.12B(+6.0%)
$297.00M(+8.0%)
$1.13B(+0.9%)
Jul 2018
-
$275.00M(+3.8%)
$1.12B(+2.2%)
Apr 2018
-
$265.00M(-8.6%)
$1.09B(+1.0%)
Jan 2018
-
$290.00M(+1.0%)
$1.08B(+2.9%)
Oct 2017
$1.05B(+7.3%)
$287.00M(+14.3%)
$1.05B(+4.8%)
Jul 2017
-
$251.00M(-1.2%)
$1.00B(+4.0%)
Apr 2017
-
$254.00M(-2.3%)
$965.00M(+6.6%)
Jan 2017
-
$260.00M(+8.8%)
$905.00M(+4.6%)
Oct 2016
$982.00M(+22.4%)
$239.00M(+12.7%)
$865.00M(+2.7%)
Jul 2016
-
$212.00M(+9.3%)
$842.00M(+1.1%)
Apr 2016
-
$194.00M(-11.8%)
$833.00M(+3.9%)
Jan 2016
-
$220.00M(+1.9%)
$802.00M(+5.4%)
Oct 2015
$802.00M(-0.7%)
$216.00M(+6.4%)
$761.00M(+20.2%)
Jul 2015
-
$203.00M(+24.5%)
$633.00M(-4.1%)
Apr 2015
-
$163.00M(-8.9%)
$660.00M(-17.9%)
Jan 2015
-
$179.00M(+103.4%)
$804.00M(-14.8%)
Oct 2014
$808.00M(-41.7%)
$88.00M(-61.7%)
$944.00M(-23.7%)
Jul 2014
-
$230.00M(-25.1%)
$1.24B(-7.3%)
Apr 2014
-
$307.00M(-3.8%)
$1.33B(-4.4%)
Jan 2014
-
$319.00M(-16.3%)
$1.40B(+0.4%)
Oct 2013
$1.39B(-4.3%)
$381.00M(+16.2%)
$1.39B(-0.5%)
Jul 2013
-
$328.00M(-10.9%)
$1.40B(-2.6%)
Apr 2013
-
$368.00M(+17.6%)
$1.44B(+0.8%)
Jan 2013
-
$313.00M(-19.3%)
$1.42B(-1.3%)
Oct 2012
$1.45B
$388.00M(+6.0%)
$1.44B(+0.7%)
Jul 2012
-
$366.00M(+2.5%)
$1.43B(+1.3%)
Apr 2012
-
$357.00M(+7.5%)
$1.41B(+1.7%)
DateAnnualQuarterlyTTM
Jan 2012
-
$332.00M(-12.2%)
$1.39B(+4.1%)
Oct 2011
$1.33B(+61.7%)
$378.00M(+8.9%)
$1.33B(+8.2%)
Jul 2011
-
$347.00M(+4.2%)
$1.23B(+15.2%)
Apr 2011
-
$333.00M(+20.2%)
$1.07B(+13.1%)
Jan 2011
-
$277.00M(0.0%)
$947.00M(+13.1%)
Oct 2010
$823.00M(+66.6%)
$277.00M(+50.5%)
$837.00M(+13.3%)
Jul 2010
-
$184.00M(-12.0%)
$739.00M(+9.8%)
Apr 2010
-
$209.00M(+25.1%)
$673.00M(+21.7%)
Jan 2010
-
$167.00M(-6.7%)
$553.00M(+10.8%)
Oct 2009
$494.00M(-50.2%)
$179.00M(+51.7%)
$499.00M(-17.9%)
Jul 2009
-
$118.00M(+32.6%)
$608.00M(-20.5%)
Apr 2009
-
$89.00M(-21.2%)
$765.00M(-16.7%)
Jan 2009
-
$113.00M(-60.8%)
$918.00M(-7.5%)
Oct 2008
$992.00M(+26.0%)
$288.00M(+4.7%)
$992.00M(+5.8%)
Jul 2008
-
$275.00M(+13.6%)
$938.00M(+6.5%)
Apr 2008
-
$242.00M(+29.4%)
$881.00M(+6.9%)
Jan 2008
-
$187.00M(-20.1%)
$824.00M(+4.7%)
Oct 2007
$787.00M(+14.9%)
$234.00M(+7.3%)
$787.00M(+6.1%)
Jul 2007
-
$218.00M(+17.8%)
$742.00M(-1.2%)
Apr 2007
-
$185.00M(+23.3%)
$751.00M(+2.0%)
Jan 2007
-
$150.00M(-20.6%)
$736.00M(+3.5%)
Oct 2006
$685.00M(+35.9%)
$189.00M(-16.7%)
$711.00M(-1.8%)
Jul 2006
-
$227.00M(+33.5%)
$724.00M(+15.5%)
Apr 2006
-
$170.00M(+36.0%)
$627.00M(+15.5%)
Jan 2006
-
$125.00M(-38.1%)
$543.00M(+7.7%)
Oct 2005
$504.00M(+1.2%)
$202.00M(+55.4%)
$504.00M(-1.4%)
Jul 2005
-
$130.00M(+51.2%)
$511.00M(-14.8%)
Apr 2005
-
$86.00M(0.0%)
$600.00M(-16.7%)
Jan 2005
-
$86.00M(-58.9%)
$720.00M(-14.2%)
Oct 2004
$498.00M(+5433.3%)
$209.00M(-4.6%)
$839.00M(+0.7%)
Jul 2004
-
$219.00M(+6.3%)
$833.00M(+27.0%)
Apr 2004
-
$206.00M(+0.5%)
$656.00M(+89.6%)
Jan 2004
-
$205.00M(+1.0%)
$346.00M(+3744.4%)
Oct 2003
$9.00M(+101.0%)
$203.00M(+383.3%)
$9.00M(+101.5%)
Jul 2003
-
$42.00M(+140.4%)
-$612.00M(+32.2%)
Apr 2003
-
-$104.00M(+21.2%)
-$903.00M(+7.8%)
Jan 2003
-
-$132.00M(+68.4%)
-$979.00M(+10.2%)
Oct 2002
-$872.00M(-253.3%)
-$418.00M(-67.9%)
-$1.09B(+3.6%)
Jul 2002
-
-$249.00M(-38.3%)
-$1.13B(-10.0%)
Apr 2002
-
-$180.00M(+25.9%)
-$1.03B(-38.2%)
Jan 2002
-
-$243.00M(+47.1%)
-$744.00M(-796.4%)
Oct 2001
$569.00M(-63.7%)
-$459.00M(-214.4%)
-$83.00M(-108.3%)
Jul 2001
-
-$146.00M(-240.4%)
$1.00B(-33.3%)
Apr 2001
-
$104.00M(-75.1%)
$1.51B(-12.4%)
Jan 2001
-
$418.00M(-33.5%)
$1.72B(+9.6%)
Oct 2000
$1.57B(+23.8%)
$629.00M(+76.7%)
$1.57B(+20.1%)
Jul 2000
-
$356.00M(+12.3%)
$1.31B(-57.0%)
Apr 2000
-
$317.00M(+18.7%)
$3.04B(-35.8%)
Jan 2000
-
$267.00M(-27.0%)
$4.73B(-24.3%)
Oct 1999
$1.27B(+17.1%)
$366.00M(-82.5%)
$6.25B(+6.2%)
Jul 1999
-
$2.09B(+3.8%)
$5.88B(+55.0%)
Apr 1999
-
$2.01B(+12.5%)
$3.80B(+112.5%)
Jan 1999
-
$1.79B
$1.79B
Oct 1998
$1.08B(-15.4%)
-
-
Oct 1997
$1.28B
-
-

FAQ

  • What is Agilent Technologies, Inc. annual EBITDA?
  • What is the all-time high annual EBITDA for Agilent Technologies, Inc.?
  • What is Agilent Technologies, Inc. annual EBITDA year-on-year change?
  • What is Agilent Technologies, Inc. quarterly EBITDA?
  • What is the all-time high quarterly EBITDA for Agilent Technologies, Inc.?
  • What is Agilent Technologies, Inc. quarterly EBITDA year-on-year change?
  • What is Agilent Technologies, Inc. TTM EBITDA?
  • What is the all-time high TTM EBITDA for Agilent Technologies, Inc.?
  • What is Agilent Technologies, Inc. TTM EBITDA year-on-year change?

What is Agilent Technologies, Inc. annual EBITDA?

The current annual EBITDA of A is $1.77B

What is the all-time high annual EBITDA for Agilent Technologies, Inc.?

Agilent Technologies, Inc. all-time high annual EBITDA is $1.90B

What is Agilent Technologies, Inc. annual EBITDA year-on-year change?

Over the past year, A annual EBITDA has changed by -$83.00M (-4.49%)

What is Agilent Technologies, Inc. quarterly EBITDA?

The current quarterly EBITDA of A is $514.00M

What is the all-time high quarterly EBITDA for Agilent Technologies, Inc.?

Agilent Technologies, Inc. all-time high quarterly EBITDA is $2.09B

What is Agilent Technologies, Inc. quarterly EBITDA year-on-year change?

Over the past year, A quarterly EBITDA has changed by +$17.00M (+3.42%)

What is Agilent Technologies, Inc. TTM EBITDA?

The current TTM EBITDA of A is $1.86B

What is the all-time high TTM EBITDA for Agilent Technologies, Inc.?

Agilent Technologies, Inc. all-time high TTM EBITDA is $6.25B

What is Agilent Technologies, Inc. TTM EBITDA year-on-year change?

Over the past year, A TTM EBITDA has changed by +$11.00M (+0.59%)
On this page